A machine learning model for diabetic retinopathy risk stratification using routine blood and urine parameters: insights into kidney-eye crosstalk

• by Yong Wang, Ling Yao, Tianpeng Chen, Qianyu Zhang, Xin Cao, Jiayi Gu, Sijie Bao, Xiaojuan Chen, Cheng Cao

• June 17, 2026

DME AWARE Study Defines Key Needs

Presenting results from the DME AWARE Delphi Study at the Association for Research in Vision and Ophthalmology (ARVO) meeting in Denver, Baruch D. Kuppermann, MD, PhD, director of the Gavin Herbert Eye Institute at the University of California, Irvine, described a set of consensus findings that point to unmet needs across the continuum of DME management, with particular emphasis on early intervention and noninvasive treatment options (Figure 1).

• by Jim Gallagher, senior managing editor

• May 1, 2026

• 5 min

Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis

• by Yitayal Abebe Gudayneh, Abebech Tewabe Gelaye, Sisay Eshete Tadesse

• April 21, 2026

Keeping an Eye on Diabetes

Progress, pitfalls and the future of the UK’s Diabetic Eye Screening Program

• by Devansh Tandon

• April 28, 2026

• 7 min